Shareholder Update - Human & Canine Trials
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurizon Therapeutics Limited on 6ix
Later from Neurizon Therapeutics
- Notice of Allowance received from USA Patent OffIce
- Appendix 4D & Half Yearly Report and Accounts
- Strategy for Phase II Clinical Trial of Monepantel
- Appendix 4C Quarterly & Company Update
- Clinical Trial in Dogs is now open for accrual
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics